Efficacy of the third-generation bisphosphonate, zoledronic acid alone and combined with anti-cancer agents against small cell lung cancer cell lines

This publication has 29 references indexed in Scilit:

• The third-generation bisphosphonate zoledronate synergistically augments the anti-Ph+ leukemia activity of imatinib mesylate
  Blood, 2003
• Advances in systemic therapy of small cell cancer of the lung
  Expert Review of Anticancer Therapy, 2001
• Chemical and biological prerequisites for novel bisphosphonate molecules: Results of comparative preclinical studies
  Seminars in Oncology, 2001
• The bisphosphonate, zoledronic acid, induces apoptosis of breast cancer cells: evidence for synergy with paclitaxel
  British Journal of Cancer, 2001
• Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma
  Experimental Hematology, 2001
• Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines
  Leukemia, 2000
• Bisphosphonates induce apoptosis in human breast cancer cell lines
  British Journal of Cancer, 2000
• Standard combination versus alternating chemotherapy in small cell lung cancer
  Lung Cancer, 1999
• Overview of bisphosphonates
  Cancer, 1997
• Chemotherapy of Lung Cancer
  New England Journal of Medicine, 1992